Edition:
United States

Neogenomics Inc (NEO.OQ)

NEO.OQ on NASDAQ Stock Exchange Capital Market

9.25USD
25 Jul 2016
Change (% chg)

-- (--)
Prev Close
$9.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
128,411
52-wk High
$9.54
52-wk Low
$5.27

NEO.OQ

Chart for NEO.OQ

About

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. Its Laboratory Testing segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The Company offers testing services, which includes... (more)

Overall

Beta: 1.44
Market Cap(Mil.): $713.34
Shares Outstanding(Mil.): 77.12
Dividend: --
Yield (%): --

Financials

  NEO.OQ Industry Sector
P/E (TTM): -- 56.79 37.05
EPS (TTM): -0.10 -- --
ROI: -0.85 5.48 14.35
ROE: -5.49 8.65 15.56

BRIEF-NeoGenomics Q2 adjusted earnings per share $0.04

* Neogenomics reports 159% revenue growth to $63.1 million and strong gains in profitability in the second quarter of 2016

7:15am EDT

BRIEF-Neogenomics files for stock shelf of up to $200 mln

* Files for stock shelf of up to $200 million - SEC filing Source text -http://1.usa.gov/24WtPQB Further company coverage:

Jun 17 2016

BRIEF-Neogenomics reports Q4 loss $0.07/shr

* Q1 earnings per share view $-0.07, revenue view $57.0 million -- Thomson Reuters I/B/E/S

Apr 27 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.